2019, BioTech, Medicare and Patient Experience

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2019

BioTech

Medicare

Patient Experience

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

JANUARY 18, 2019

I’m glad to be getting back to health economic issues after spending the last couple of weeks firmly focused on consumers, digital health technologies and CES 2019. From 2003 to 2019, the theory that prices are the primary driver of America’s spending more on health care than any other country is still the case.

BioTech

BioTech Medicare Medical Billing Patient Experience

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Health Populi

MARCH 6, 2019

There’s little Americans, by political party, agree upon in 2019. is prescription drug prices — that they’re too high, that the Federal government should negotiate to lower costs for Medicare enrollees, and that out-of-pocket costs for drugs should be limited.

Pharmaceuticals

Pharmaceuticals Life Science Medicare BioTech

Connected Health Pulse

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Most Americans Across Party ID Favor U.S. Government Negotiation to Lower Rx Drug Costs

Stay Connected